【レポートの概要(一部)】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Key buying criteria
PART 05: Disease overview
• Types of myocardial infarction
• Pathophysiology
• Risk factors
• Diagnosis
• Management
PART 06: Epidemiology and economic burden
• Burden of disease
PART 07: Pipeline analysis
• Canakinumab
• MyoCell
• MultiStem therapy
• CLBS10
• Prochymal
• Revascor
• CicloMulsion
• PP-099
• NP202
• CAP-1002
• Revacept
• CSL112
PART 08: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 09: Market segmentation by drug class
• Beta blockers
• ACE inhibitors
• ARBs
• Vasodilators
• Antithrombotic agents
• Thrombolytics
• Glycoprotein IIb/IIIa inhibitors
• Anti-dyslipidemic drugs
• Calcium channel blockers
• Analgesics
PART 10: Market segmentation by EKG appearance
• NSTEMI
• STEMI
PART 11: Market segmentation by type
• Brand-name drugs
• Generic drugs
PART 12: Geographical segmentation
• Global myocardial infarction drugs market segmentation by geography 2015-2020
• Myocardial infarction drugs market in Americas
• Myocardial infarction drugs market in EMEA
• Myocardial infarction drugs market in APAC
PART 13: Market drivers
• Increase in older population
• Sedentary lifestyle
• Rise in obesity
• High prevalence of chronic conditions
PART 14: Impact of drivers
PART 15: Market challenges
• Delayed diagnosis
• Alternative therapies
• Extensive use of generics
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Growing awareness of disease
• Strategic alliances
• Increased R&D
• Prevalent use of stent grafts
PART 18: Vendor landscape
• Competitive scenario
• AstraZeneca
• Bayer HealthCare
• Eli Lilly
• Novartis
• Pfizer
• Sanofi
• Other prominent vendors
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for myocardial infarction drugs
Exhibit 03: Pathophysiology of myocardial infarction
Exhibit 04: Risk factors of myocardial infarction
Exhibit 05: Diagnostic techniques for myocardial infarction
Exhibit 06: Treatment options for myocardial infarction
Exhibit 07: Projected prevalence of CVDs in US
Exhibit 08: Projected economic burden for CVDs in US
Exhibit 09: Pipeline portfolio: Myocardial infarction
Exhibit 10: Global myocardial infarction drugs market 2015-2020 ($ billions)
Exhibit 11: Five forces analysis
Exhibit 12: Global myocardial infarction drugs market segmentation by EKG appearance 2015
Exhibit 13: Global myocardial infarction drugs market segmentation by type 2015
Exhibit 14: Global myocardial infarction drugs market segmentation by geography 2015
Exhibit 15: Myocardial infarction drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 16: Myocardial infarction drugs market in Americas 2015-2020 ($ billions)
Exhibit 17: Myocardial infarction drugs market in EMEA 2015-2020 ($ billions)
Exhibit 18: Myocardial infarction drugs market in APAC 2015-2020 ($ billions)
Exhibit 19: Global myocardial infarction drugs market: YoY growth and revenue based on geography 2015-2020
Exhibit 20: Impact of drivers
Exhibit 21: Impact of drivers and challenges
Exhibit 22: AstraZeneca: Business segmentation by revenue 2014
Exhibit 23: AstraZeneca: Cardiovascular and metabolic diseases segment by revenue 2014
Exhibit 24: AstraZeneca: YoY revenue and growth rate of Crestor 2012-2014 ($ billions)
Exhibit 25: AstraZeneca: YoY revenue and growth rate of Seloken/Toprol 2012-2014 ($ millions)
Exhibit 26: AstraZeneca: YoY revenue and growth rate of Atacand 2012-2014 ($ millions)
Exhibit 27: AstraZeneca: YoY revenue and growth rate of Brilinta/Brilique 2012-2014 ($ millions)
Exhibit 28: AstraZeneca: Key takeaways
Exhibit 29: Bayer HealthCare: YoY revenue and growth rate of Xarelto 2012-2014 ($ millions)
Exhibit 30: Bayer HealthCare: YoY revenue and growth rate of Adalat 2012-2014 ($ millions)
Exhibit 31: Bayer HealthCare: Key takeaways
Exhibit 32: Eli Lilly: YoY revenue and growth rate of Effient (global) 2012-2015 ($ millions)
Exhibit 33: Eli Lilly: YoY revenue and growth rate of Effient in US 2012-2015 ($ millions)
Exhibit 34: Eli Lilly: YoY revenue and growth rate of Effient in rest of world 2012-2015 ($ millions)
Exhibit 35: Eli Lilly: Key takeaways
Exhibit 36: Novartis: YoY revenue and growth rate of Diovan 2012-2015 ($ billions)
Exhibit 37: Novartis: YoY revenue and growth rate of Exforge 2012-2015 ($ billions)
Exhibit 38: Novartis: Key takeaways
Exhibit 39: Pfizer: YoY revenue and growth rate of Lipitor 2012-2014 ($ billions)
Exhibit 40: Pfizer: YoY revenue and growth rate of Norvasc 2012-2014 ($ billions)
Exhibit 41: Pfizer: YoY revenue and growth rate of Fragmin 2012-2014 ($ millions)
Exhibit 42: Pfizer: YoY revenue and growth rate of Caduet 2012-2014 ($ millions)
Exhibit 43: Pfizer: Key takeaways
Exhibit 44: Sanofi: YoY revenue and growth rate of Plavix 2012-2014 ($ billions)
Exhibit 45: Sanofi: YoY revenue and growth rate of Lovenox 2012-2014 ($ billions)
Exhibit 46: Sanofi: Key takeaways
【レポート販売概要】
■ タイトル:心筋梗塞治療薬の世界市場2016-2020■ 英文:Global Myocardial Infarction Drugs Market 2016-2020
■ 発行日:2016年3月8日
■ 調査会社:Technavio
■ 商品コード:IRTNTR8952
■ 調査対象地域:グローバル
- インシデント及びエマージェンシー管理の世界市場予測(~2021年)MarketsandMarkets forecasts the incident and emergency management market size to grow from USD 88.58 Billion in 2016 to USD 114.01 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 5.2%. Ever-changing climatic conditions across the globe, increased government regulations and norms, extensive usage of social-media to spread information, and increased terrorist attacks are the major drivin …
- スマート鉄道システムの世界市場2016-2020About Smart Railways Systems Traffic congestion on roadways and airways has increased the demand for railway transport. It is more feasible and convenient for passengers to travel by train than any other mode of transportation as it can provide faster services at a reasonable price. Moreover, railways are considered as a faster and safer option compared with roadways. The increase in demand for ra …
- ブラジルの気道装置・麻酔装置市場Brazil Airway and Anesthesia Devices Market Outlook to 2021 Summary GlobalData’s new report, "Brazil Airway and Anesthesia Devices Market Outlook to 2021", provides key market data on the Brazil Airway and Anesthesia market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Anesthesia Circuits, Anesthesia Masks, …
- 風力発電タワーの世界市場2015-2019Technavios market research analyst has estimated that the prospect for growth in this market is strongly driven by the wind energy industry, which is influenced by the rising environmental concerns, increased power demand, favorable government support, and the rising need to reduce dependency on fossil fuels. These factors are expected to stimulate the prospects for growth in this market and resul …
- 世界の分子診断市場This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as test volume and sales forecasts by country. The report also presents strategic profiles of current and emerging suppliers of molecular diagnostic products in terms of their sales, product portfolios, marketing tactic …
- 農業検査の世界市場:土壌検査、水質検査、肥料検査、堆肥検査、バイオソリッド検査、種子検査The agricultural testing market has grown exponentially in the last few years and this trend is projected to continue. The agricultural testing market was valued at $3,997.40 million in 2014; it is projected to reach $5,641.56 million by 2020, at a CAGR of 5.9% from 2015. The market is driven by factors such as rules and regulations laid by governments for the development of agriculture and the gr …
- 重要臓器支援システム・メディカルバイオニクスの世界市場:製品別(重要臓器支援システム、メディカルバイオニクス)、エンドユーザー別(病院、外来手術センター、その他)The global vital organs support systems and medical bionics market size in 2017 is $28,169 million, and is projected to reach $59,412 million by 2025, growing at a CAGR of 10.9% from 2018 to 2025. An artificial organ is an engineered device or tissue that is implanted or integrated into a human, interfacing with living tissue. Medical bionics, also known as biomedical implants, are artificial addi …
- スポーツ用品用複合材料の世界市場:炭素繊維、ガラス繊維、その他The global market size of composites-based sporting goods, in terms of value, is projected to reach USD 3.75 Billion by 2021, registering a CAGR of 5.59% between 2016 and 2021. The increasing number of patents filed for composites-based sporting goods by global players, growing manufacturing industries, and continuous new product launches, agreements, and expansion activities undertaken by compani …
- 好中球減少症治療薬の世界市場About Neutropenia Treatment Neutropenia is an abnormal condition, characterized by critically low levels of circulating neutrophils, a type of WBC found in the blood. These cells make up for the majority of circulating lymphocytes and help defend the body against infections by bacteria, viruses, and other pathogenic organisms. Decrease in the neutrophil count in blood makes a patient susceptible t …
- ホームセキュリティシステムの世界市場:セキュリティカメラ、電子/スマートロック、センサー、感知器、アラーム、セキュリティソリューション、DIYホームセキュリティThe rising incidents of security concerns has led to increased safety measures by residential dwellings. As a result, the global home security system market is projected to grow at a remarkable rate of above 13% during the forecast period. Advancement in technology and emergence of smart homes has led to the rise of integrated home security systems, which can be connected to smartphones and enable …
- 分布型温度センシング(DTS)システムの世界市場:OTDR/OFDR原理、ファイバー種類、用途、地域別分析Conventional temperature measurement systems are inconvenient to use in harsh operating environments. They are susceptible to electromagnetic interference, extremely high temperatures, and corrosion in humid conditions. In the oil &gas industry, temperature measurement is an important requirement for applications such as downhole reservoir monitoring and well completion. Some applications require …
- イギリスの末梢血管処置用機器市場見通し(~2021)United Kingdom Peripheral Vascular Procedures Outlook to 2021 Summary GlobalData’s new report, "United Kingdom Peripheral Vascular Procedures Outlook to 2021", provides key procedures data on the United Kingdom Peripheral Vascular Procedures. The report provides procedure volumes within market segments - Aortic Open Repair Procedures, Aortic Stent Graft Procedures, Carotid Artery Embolic Protectio …
- 世界のフローサイトメトリー市場:装置、試薬、消耗品About Flow Cytometry Flow cytometry is a technique of measuring the properties of cells in a fluid suspension. Flow cytometry focuses a beam of light onto a hydro dynamically focused stream of fluid. Flow cytometers can analyze thousands of particles in a short span of time. They can separate and isolate particles with specified properties. The analysis of multiple parameters of individual cells i …
- ベビーフードの米国市場:製品種類別(ベビーフードの準備、ベビーフードの乾燥、シリアル、その他)、流通経路別(ハイパーマーケットとスーパーマーケット、独立した食料品店、専門店、消費者直販、オンラインストア)Baby food implies to the food prepared for infants aged from four-six months and two years up to nine years. It is primarily made up of minced and mashed vegetables, cereals, meats, and fruits. In the recent years, packaged baby food has been widely adopted by parents since it provides convenience and higher nutrition level. In addition, the rise in awareness among people about the numerous health …
- 機内エンターテインメント(IFE)の世界市場予測(~2022)The inflight entertainment (IFE) market is projected to grow from an estimated USD 3.18 Billion in 2016 to USD 6.91 Billion by 2022, at a CAGR of 13.80% during the forecast period. Enhancing passenger experience, new technology development, and major source of ancillary revenue for airlines through inflight entertainment (IFE) are key factors expected to drive the inflight entertainment (IFE) mark …